{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:58:41Z","timestamp":1792450721943,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.yrtph.2009.01.007","type":"journal-article","created":{"date-parts":[[2009,1,27]],"date-time":"2009-01-27T10:04:22Z","timestamp":1233050662000},"page":"43-65","source":"Crossref","is-referenced-by-count":40,"title":["Identification of structure\u2013activity relationships for adverse effects of pharmaceuticals in humans: Part C: Use of QSAR and an expert system for the estimation of the mechanism of action of drug-induced hepatobiliary and urinary tract toxicities"],"prefix":"10.1016","volume":"54","author":[{"given":"Edwin J.","family":"Matthews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi L.","family":"Kruhlak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Daniel Benz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Aragon\u00e9s","family":"Sabat\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Marchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Contrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2009.01.007_bib1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2165\/00002018-200629100-00005","article-title":"Comparative performance of two quantitative safety signaling methods","volume":"29","author":"Almenoff","year":"2006","journal-title":"Drug Saf."},{"issue":"Suppl. 2","key":"10.1016\/j.yrtph.2009.01.007_bib2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1600-0773.1986.tb02536.x","article-title":"Effects of calcium channel blockers on urinary tract smooth muscle","volume":"58","author":"Andersson","year":"1986","journal-title":"Acta Pharmacol. Toxicol. (Copenh)."},{"key":"10.1016\/j.yrtph.2009.01.007_bib3","doi-asserted-by":"crossref","unstructured":"Aronov, A.M., Konstantin, V.B., Kiselyou, A., Varma-O\u2019Brien, S., Elkins, S., 2007. Applications of QSAR methods to ion channels. Computational Toxicology: Risk Assessment for Pharmaceuticals and Environmental Chemicals. In: Elkins, S. (Ed.), John Wiley & Sons. Inc, Hoboken, NJ, pp. 353-389.","DOI":"10.1002\/9780470145890.ch13"},{"key":"10.1016\/j.yrtph.2009.01.007_bib4","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1021\/cr030049y","article-title":"Structure\u2013activity relationship studies of chemical mutagens and carcinogens: mechanistic investigations and prediction approaches","volume":"105","author":"Benigni","year":"2005","journal-title":"Chem. Rev."},{"key":"10.1016\/j.yrtph.2009.01.007_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1517\/17425255.3.1.109","article-title":"Toxicological and clinical computational analysis and the US FDA\/CDER","volume":"3","author":"Benz","year":"2007","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.yrtph.2009.01.007_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/bjc.1979.10","article-title":"Describing the validity of carcinogen screening tests","volume":"39","author":"Cooper","year":"1979","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yrtph.2009.01.007_bib7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0092-8674(95)90358-5","article-title":"A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome","volume":"80","author":"Curren","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.yrtph.2009.01.007_bib8","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1021\/jm040180d","article-title":"Cytochrome P450 in silico: an integrative modeling approach","volume":"48","author":"de Graaf","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yrtph.2009.01.007_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2307\/2686093","article-title":"Bayesian data mining in large frequency tables, with an application to the FDA Spontaneous Reporting System","volume":"53","author":"DuMouchel","year":"1999","journal-title":"Am. Stat."},{"key":"10.1016\/j.yrtph.2009.01.007_bib10","doi-asserted-by":"crossref","unstructured":"Ekins, S., 2007. Applications of QSAR to enzymes involved in toxicology. Computational Toxicology: Risk Assessment for Pharmaceuticals and Environmental Chemicals. In: Elkins, S. (Ed.), John Wiley & Sons, Inc., pp. 277\u2013293.","DOI":"10.1002\/9780470145890.ch10"},{"key":"10.1016\/j.yrtph.2009.01.007_bib11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/pds.677","article-title":"Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports","volume":"10","author":"Evans","year":"2001","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.yrtph.2009.01.007_bib12","doi-asserted-by":"crossref","unstructured":"Fix, E., Hodges, J.L., 1951. Discriminatory analysis, nonparametric discrimination, consistency properties, Technical Report 4, United States Air Force, School of Aviation Medicine, Randolph Field, TX, pp. 261\u2013279.","DOI":"10.1037\/e471672008-001"},{"key":"10.1016\/j.yrtph.2009.01.007_bib13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/009286150103500134","article-title":"Evaluation of the characteristics of safety withdrawal of prescription drugs from worldwide pharmaceutical markets-1960 to 1999","volume":"25","author":"Fung","year":"2001","journal-title":"J. Drug Inform."},{"key":"10.1016\/j.yrtph.2009.01.007_bib14","first-page":"307","article-title":"Receiver operating characteristic (ROC) methodology: the state of the art","volume":"29","author":"Hanley","year":"1989","journal-title":"Crit. Rev. Diagn. Imaging"},{"key":"10.1016\/j.yrtph.2009.01.007_bib15","unstructured":"Harrison\u2019s Principles of Internal Medicine, 17th Edition, 2008. (http:\/\/www.accessmedicine.com\/)."},{"key":"10.1016\/j.yrtph.2009.01.007_bib16","first-page":"29","article-title":"Computational toxicology: heading toward more relevance in drug discovery and development","volume":"9","author":"Johnson","year":"2006","journal-title":"Curr. Opin. Drug Disc. Devel."},{"key":"10.1016\/j.yrtph.2009.01.007_bib17","doi-asserted-by":"crossref","unstructured":"Johnson, D.E., Rodgers, A.D., Sudarsanam, S., 2007. Future of Computational Toxicology: Broad Application into human disease and therapeutics. Computational Toxicology: Risk Assessment for Pharmaceuticals and Environmental Chemicals. In: Elkins, S. (Ed.), John Wiley & Sons, Inc., pp.725\u2013749.","DOI":"10.1002\/9780470145890.ch26"},{"key":"10.1016\/j.yrtph.2009.01.007_bib18","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1021\/ci020272g","article-title":"Using argumentation for absolute reasoning about the potential toxicity of chemicals","volume":"43","author":"Judson","year":"2003","journal-title":"J. Chem. Inform. Comp. Sci."},{"key":"10.1016\/j.yrtph.2009.01.007_bib19","doi-asserted-by":"crossref","unstructured":"Lill, M.A., Vedani, A., 2007. Computational modeling of receptor-mediated toxicity. Computational Toxicology: Risk Assessment for Pharmaceuticals and Environmental Chemicals. Edited S. Elkins. John Wiley & Sons, Inc. pp. 315\u2013351.","DOI":"10.1002\/9780470145890.ch12"},{"key":"10.1016\/j.yrtph.2009.01.007_bib20","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.171.3977.1217","article-title":"Signal detectability and medical decision-making","volume":"171","author":"Lusted","year":"1971","journal-title":"Science"},{"key":"10.1016\/j.yrtph.2009.01.007_bib21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/15376510701857320","article-title":"In silico tools for sharing data and knowledge on toxicity and metabolism: Derek for Windows, Meteor, and Vitic","volume":"18","author":"Marchant","year":"2008","journal-title":"Toxicol. Mech. Meth."},{"key":"10.1016\/j.yrtph.2009.01.007_bibisn1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1517\/17425255.3.1.125","article-title":"In Silico approaches to explore toxicity endpoints: issues and concerns for estimating human health effects","volume":"3","author":"Matthews","year":"2007","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.yrtph.2009.01.007_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/15376510701857379","article-title":"Combined use of MC4PC, MDL-QSAR, BioEpisteme, Leadscope PDM, and Derek for Windows software to achieve high performance, high confidence, mode of action-based predictions of chemical carcinogenesis in rodents","volume":"18","author":"Matthews","year":"2008","journal-title":"Toxicol. Mech. Meth."},{"key":"10.1016\/j.yrtph.2009.01.007_bib24","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yrtph.2005.11.003","article-title":"An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpoints","volume":"44","author":"Matthews","year":"2006","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.01.007_bib25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.yrtph.2005.10.004","article-title":"An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methods","volume":"44","author":"Matthews","year":"2006","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.01.007_bib26","doi-asserted-by":"crossref","unstructured":"Matthews, E.J., Kruhlak, N.L., Weaver, J.L., Benz, R.D., Contrera, J.F., 2004. Assessment of the health effects of chemicals in humans: II. construction of an adverse effects database for QSAR modeling. Curr. Drug Discov. Technol. 1, 243\u2013254.","DOI":"10.2174\/1570163043334794"},{"key":"10.1016\/j.yrtph.2009.01.007_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.yrtph.2009.01.009","article-title":"Identification of structure\u2013activity relationships for adverse effects of pharmaceuticals in humans: B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicities","volume":"54","author":"Matthews","year":"2009","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.01.007_bib28","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/pds.1058","article-title":"The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions","volume":"14","author":"Moore","year":"2005","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.yrtph.2009.01.007_bib29","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMra052270","article-title":"Drug related hepatotoxicity","volume":"354","author":"Navarro","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yrtph.2009.01.007_bib30","unstructured":"OECD Guidance. Guidance document on the validation of (quantitative) structure\u2013activity relationship [Q)SAR] models. OECD environment health and safety publications series on testing and assessment No. XX. (May 2006)."},{"key":"10.1016\/j.yrtph.2009.01.007_bib31","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1023\/A:1007601015854","article-title":"Robust classification for imprecise environments","volume":"42","author":"Provost","year":"2001","journal-title":"Mach. Learn. J."},{"issue":"Suppl. 2","key":"10.1016\/j.yrtph.2009.01.007_bib32","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1038\/sj.bjp.0706504","article-title":"The role of central 5-hydroxytryptamine (5-HT, serotonin) receptors in the control of micturition","volume":"147","author":"Ramage","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.01.007_bib33","doi-asserted-by":"crossref","unstructured":"Reisfeld, B., Mayeno, A.N., Lyons, M.A., Yang, R.S.H., 2007. Physiological based pharacokinetic and pharmacodynamic modeling. Computational Toxicology: Risk Assessment for Pharmaceuticals and Environmental Chemicals. In: Elkins, S. (Ed.), John Wiley & Sons, Inc., pp. 34\u201369.","DOI":"10.1002\/9780470145890.ch3"},{"key":"10.1016\/j.yrtph.2009.01.007_bib34","unstructured":"Salillas, J., Prous, J., Aragones, D., 2004. Computer aided screening for HIV antiviral activity in the open NCI database. XVIII\u2019th International Symposium on Medicinal Chemistry. Copenhagen, Denmark & Malmo, Sweden. Poster 18."},{"key":"10.1016\/j.yrtph.2009.01.007_bib35","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJM198109243051302","article-title":"Predisposition to phenytoin hepatotoxicity assessed in vitro","volume":"305","author":"Spielberg","year":"1981","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yrtph.2009.01.007_bib36","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00002018-200225060-00001","article-title":"Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA\u2019s spontaneous reports database","volume":"25","author":"Szarfman","year":"2003","journal-title":"Drug Saf."},{"key":"10.1016\/j.yrtph.2009.01.007_bib37","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1592\/phco.24.13.1099.38090","article-title":"Pharmacovigilance in the 21st century: New systematic tools for an old problem","volume":"24","author":"Szarfman","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.yrtph.2009.01.007_bib38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1358\/mf.2005.27.5.908643","article-title":"Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipyschotics to induce type 2 diabetes","volume":"27","author":"Silvestre","year":"2005","journal-title":"Meth. Find. Exp. Clin. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.01.007_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yrtph.2008.12.009","article-title":"Identification of structure\u2013activity relationships for adverse effects of pharmaceuticals in humans A: Use of FDA post market reports to create a database of hepatobiliary and urinary tract toxicities","volume":"54","author":"Ursem","year":"2009","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2009.01.007_bib40","doi-asserted-by":"crossref","first-page":"R1414","DOI":"10.1152\/ajpregu.2001.280.5.R1414","article-title":"Role of spinal \u03b11-adrenoceptor subtypes in the bladder reflex in anesthetized rats","volume":"280","author":"Yoshiyama","year":"2001","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230009000117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230009000117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T15:36:58Z","timestamp":1709998618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230009000117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0273230009000117"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2009.01.007","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}